Mike Sorrentino is a Senior Editor for Mobile, covering phones, texting apps and smartwatches -- obsessing about how we can make the most of them. Mike also keeps an eye out on the movie and toy ...

AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...